VIATRIS INC. Other Comprehensive Income (Loss), Unrealized Gain (Loss) on Derivatives Arising During Period, before Tax
VIATRIS INC. (VTRS) reported Other Comprehensive Income (Loss), Unrealized Gain (Loss) on Derivatives Arising During Period, before Tax of $145.10 million for the 3-month period ending 2021-09-30, per its 10-Q filed 2021-11-08.
Discontinued › Income Statement › Other Income
us-gaap:OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax · last filed 2021-11-08
- VIATRIS INC. other comprehensive income (loss), unrealized gain (loss) on derivatives arising during period, before tax for the quarter ending 2021-09-30 was $145.10M.
- VIATRIS INC. other comprehensive income (loss), unrealized gain (loss) on derivatives arising during period, before tax for the quarter ending 2021-06-30 was -$49.20M.
- VIATRIS INC. other comprehensive income (loss), unrealized gain (loss) on derivatives arising during period, before tax for the quarter ending 2021-03-31 was $263.40M.
- VIATRIS INC. other comprehensive income (loss), unrealized gain (loss) on derivatives arising during period, before tax for the quarter ending 2020-09-30 was -$79.50M.
| Period end | Other Comprehensive Income (Loss), Unrealized Gain (Loss) on Derivatives Arising During Period, before Tax 3 month | Other Comprehensive Income (Loss), Unrealized Gain (Loss) on Derivatives Arising During Period, before Tax 6 month | Other Comprehensive Income (Loss), Unrealized Gain (Loss) on Derivatives Arising During Period, before Tax 9 month |
|---|---|---|---|
| 2021-09-30 | $145.10M 10-Q · filed 2021-11-08 | $95.90M derived: sum of 2 quarters · filed 2021-11-08 | $359.30M 10-Q · filed 2021-11-08 |
| 2021-06-30 | -$49.20M 10-Q · filed 2021-08-09 | $214.20M 10-Q · filed 2021-08-09 | |
| 2021-03-31 | $263.40M 10-Q · filed 2021-05-10 | ||
| 2020-09-30 | -$79.50M 10-Q · filed 2021-11-08 | -$111.60M derived: sum of 2 quarters · filed 2021-11-08 | -$114.30M 10-Q · filed 2021-11-08 |
| 2020-06-30 | -$32.10M 10-Q · filed 2021-08-09 | -$34.80M 10-Q · filed 2021-08-09 | |
| 2020-03-31 | -$2.70M 10-Q · filed 2021-05-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| UNITED THERAPEUTICS Corp (UTHR) | United States | $20.249B | 17.64 |
| Royalty Pharma plc (RPRX) | United States | $22.628B | |
| Jazz Pharmaceuticals plc (JAZZ) | $15.333B | 16.07 | |
| Roivant Sciences Ltd. (ROIV) | $26.105B | -96.08 | |
| INSMED Inc (INSM) | United States | $26.566B | -26.60 |
| Summit Therapeutics Inc. (SMMT) | United States | $13.071B | -13.21 |
| BridgeBio Pharma, Inc. (BBIO) | United States | $12.947B | -20.72 |
| CORCEPT THERAPEUTICS INC (CORT) | United States | $12.804B | 169.10 |
| BIOMARIN PHARMACEUTICAL INC (BMRN) | United States | $11.879B | 151.80 |
| MADRIGAL PHARMACEUTICALS, INC. (MDGL) | United States | $11.859B | -38.17 |